| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 21.40 | 3.4% | 13.7% |
| Total Income | 21.40 | 3.4% | 13.7% |
| Expenditure | 20.17 | 7.5% | 11.4% |
| PBT | 1.23 | 267.0% | 72.6% |
| Net Profit | 0.91 | 285.5% | 72.8% |
| OPM | 8.02% | 4.63pp | 6.34pp |
| NPM | 4.27% | 3.20pp | 1.46pp |
| EPS | 0.37 | 270.0% | 42.3% |
Deccan Health Care Ltd Announces Strong Financial Performance for Q2 & H1 FY 2025-26
14 Nov 2025 · 14 Nov 2025, 04:42 pm
Summary
Deccan Health Care Ltd has reported a robust operational and financial performance for the quarter and half-year ended 30 September 2025, demonstrating the company’s robust revenue growth trajectory, healthy profitability and strategic focus on innovation-led, preventive healthcare solutions.
Key Highlights
- 1
Revenue from Operations: Standalone Quarter Performance: 32,440.46 lakh T Growth: +29.7% YoY
- 2
Standalone Half-Year Performance: 34,587.41 lakh T Growth: +35.4% YoY
- 3
Consolidated Quarter Performance: 32,139.56 lakh
- 4
Consolidated Half-Year Performance: 24,353.58 lakh
- 5
Net Profit: Standalone Quarterly PAT: 289.97 lakh | Up: 67.5% YoY
- 6
Standalone Half-Year PAT: 111.22 lakh T Up: 22.8% YoY
- 7
Consolidated Quarterly PAT: 391.40 lakh
- 8
Consolidated Half-Year PAT: 115.11 lakh EPS steady and improving, signalling value accretion
- 9
Zero investor complaints — strong governance
- 10
Broadened its wellness portfolio with innovative launches
- 11
Introduced its pioneering Weight Wellness Program
- 12
Expanding global footprint with regulatory filings completed in six international markets and product launches in the UAE and GCC planned for March 2026
Management Comments
Mr Mohak from Deccan Health Care
Our Q2 performance demonstrates the resilience of our model and rising consumer preference for preventive, scientific wellness. We remain focused on disciplined execution, export-readiness, and sustained long-term value creation.
Informational and educational content only. Not investment advice.